Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Plos Neglected Tropical Diseases|May 8, 2018
Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of CongoLouis Albert Massing, Soumah Aboubakar, Alexandre Blake, et al.Tropical Medicine & International Health : TM & IH|June 1, 2018
Evaluation of the SD bioline cholera rapid diagnostic test during the 2016 cholera outbreak in Lusaka, ZambiaJohn Mwaba, Eva Ferreras, Elizabeth Chizema-Kawesa, et al.Journal of Health, Population, and Nutrition|December 22, 2004
The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in AsiaCamilo J Acosta, Claudia M Galindo, R Leon Ochiai, et al.Bulletin of the World Health Organization|April 29, 2008
A study of typhoid fever in five Asian countries: disease burden and implications for controlsR Leon Ochiai, Camilo J Acosta, M Carolina Danovaro-Holliday, et al.Plos One|December 20, 2016
Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to CultureLameck N Ontweka, Lul O Deng, Jean Rauzier, et al.The Lancet. Global Health|October 22, 2016
Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort studyAndrew S Azman, Lucy A Parker, John Rumunu, et al.BMC Public Health|May 21, 2005
A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trialJin Yang, Camilo J Acosta, Guo-ai Si, et al.Vaccine|December 5, 2006
Implementation of good clinical practice guidelines in vaccine trials in developing countriesCamilo J Acosta, Claudia M Galindo, R Leon Ochiai, et al.Tropical Medicine & International Health : TM & IH|December 20, 2005
A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and designCamilo J Acosta, Claudia M Galindo, Mohammad Ali, et al.Vaccine|January 1, 2013
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt, Danny Altmann, Abraham Aseffa, et al.Pageof 7